115. All-trans retinoic acid drug development at the national cancer institute (NCI)
DR Parkinson +4 more
openaire +1 more source
Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2. [PDF]
Coleman N +25 more
europepmc +1 more source
Toward the simultaneous detection of multiple diseases with a highly cost-effective cell-free DNA methylome test. [PDF]
Zeng W +53 more
europepmc +1 more source
Cancer Treatment-Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration. [PDF]
Meng X +18 more
europepmc +1 more source
Associations between Perceived Costs and Rewards of Sun Protection and Sun Safety Practices among Rural and Urban High School Students. [PDF]
Anwar OU +11 more
europepmc +1 more source
Capturing Latino Health Disparities: Lessons from Mail- and Community-Based Population Health Surveys in California. [PDF]
Vang AP +8 more
europepmc +1 more source
Effect of metformin on pancreatic neuroendocrine tumors of multiple endocrine neoplasia type 1. [PDF]
Kozlov SV +9 more
europepmc +1 more source
Discovery of a First-in-Class Murine Double Minute 2-Recruiting Positive Transcription Elongation Factor B PROTAC Degrader With Selective Antitumor Activity. [PDF]
Guan X +16 more
europepmc +1 more source
Retraction Note: Predicting cancer prognosis and drug response from the tumor microbiome
Leandro C. Hermida +2 more
doaj +1 more source
(Giga)TIME for the era of AI: virtual multiplex immunofluorescence from routine H&E for large populations. [PDF]
Yang SP, Yu D.
europepmc +1 more source

